Cargando…

Editorial: Innovative Biologics and Drugs to Target Renal Inflammation

Detalles Bibliográficos
Autores principales:	Griffin, Matthew D., Swaminathan, Sundararaman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016012/ https://www.ncbi.nlm.nih.gov/pubmed/32116714 http://dx.doi.org/10.3389/fphar.2020.00038

Ejemplares similares

Innovative Drugs to Target Renal Inflammation in Sepsis: Alkaline Phosphatase
por: Hümmeke-Oppers, Femke, et al.
Publicado: (2019)

Editorial: Insights in renal pharmacology: 2021
por: Perico, Norberto, et al.
Publicado: (2022)

Editorial: Targeting the Chemoattractant System in Inflammation
por: Hosoya, Tadashi, et al.
Publicado: (2021)

Editorial: Innovative pharmacometric approaches to inform drug development and clinical use
por: Garcia-Cremades, Maria, et al.
Publicado: (2023)

Editorial: Leukocyte biology and muscle pathology: Leukocytes as potential targets to control muscle inflammation, mass, and pain
por: Hohmann, Miriam S. N., et al.
Publicado: (2023)

Editorial: Biological drugs and biosimilars in autoimmune diseases
por: Wajda, Anna, et al.
Publicado: (2023)

Editorial: Pharmacological Approaches Targeting Neutrophilic Inflammation
por: Chernyak, Boris V., et al.
Publicado: (2021)

Editorial: Targeting inflammation to prevent complications in stroke
por: Varela, Lourdes M., et al.
Publicado: (2023)

Editorial: Innovation in ocular pharmacology
por: Gozzo, Lucia, et al.
Publicado: (2023)

Editorial: Anakoinosis: An Innovative Anticancer Therapy Targeting the Aberrant Cancer Tissue Homeostasis
por: Heudobler, Daniel, et al.
Publicado: (2021)

Editorial: Targeting Monocytes/Macrophages to Treat Atherosclerotic Inflammation
por: Corti, Alessandro, et al.
Publicado: (2020)

Editorial: Metalloenzymes: Potential Drug Targets
por: Iqbal, Jamshed, et al.
Publicado: (2021)

Editorial: The challenges of drug repurposing in diseases related to chronic inflammation
por: Collotta, Debora, et al.
Publicado: (2023)

Editorial: Stem Cells as Targeted Drug Delivery Vehicles
por: Kusuma, Gina D., et al.
Publicado: (2020)

Editorial: Inflammation and Fibrosis in the Gastrointestinal Tract and Liver: Mechanisms and Targets
por: Weiskirchen, Ralf, et al.
Publicado: (2021)

Editorial: Pharmacological approaches targeting neutrophilic inflammation: Volume II
por: Sokolov, Alexey V., et al.
Publicado: (2022)

Editorial: Inflammation and immune diseases: Molecular targets for pathogenesis and treatment
por: Wu, Fan-Rong
Publicado: (2023)

Editorial: Pharmaceutical Innovation After World War II: From Rational Drug Discovery to Biopharmaceuticals
por: Zarros, Apostolos, et al.
Publicado: (2019)

Editorial: Orphan GPCRs As Emerging Drug Targets
por: Fang, Ye, et al.
Publicado: (2015)

Editorial: Bypassing the Biological Barriers by Means of Biocompatible Drug Delivery Systems
por: Awasthi, Vibhudutta, et al.
Publicado: (2021)

Editorial: Ferroptosis as a novel therapeutic target for inflammation-related diseases
por: Liang, Yongyi, et al.
Publicado: (2023)

Editorial: Phosphodiesterases as Drug Targets in Airway and Inflammatory Diseases
por: Mokry, Juraj, et al.
Publicado: (2021)

Editorial: Adenylyl cyclase isoforms as potential drug targets
por: Brust, Tarsis F., et al.
Publicado: (2022)

Editorial: C. elegans as an emerging model of pharmacological innovation
por: Huang, Zebo, et al.
Publicado: (2022)

Editorial: New Paradigms in Neuroscience and Related Targets for Drug Discovery
por: Salomone, Salvatore
Publicado: (2020)

Editorial: Drug Development and Target Discovery in Pulmonary Vascular Diseases
por: Zhang, Rui, et al.
Publicado: (2020)

Editorial: Antimycobacterial drug discovery: Molecular therapeutics and target identification
por: Gunosewoyo, Hendra, et al.
Publicado: (2022)

Editorial: Lymphatic delivery and targeting of drugs, vaccines, and imaging agents
por: Han, Sifei, et al.
Publicado: (2022)

Editorial: Novel therapeutic target and drug discovery for neurological diseases
por: Zhao, Kaiyue, et al.
Publicado: (2022)

Editorial: Novel therapeutic approaches to target drug resistant tumors
por: Riganti, Chiara, et al.
Publicado: (2023)

Editorial: Cancer neuroscience: Drug repurposing targeting the innervated niche
por: Jin, Ming-Zhu, et al.
Publicado: (2023)

Editorial: Innovators in chemical biology
por: Wade, John D., et al.
Publicado: (2022)

Editorial: New compounds, novel targets and mechanism study in inflammation-associated liver diseases
por: Wu, Baoming
Publicado: (2022)

Editorial: Therapeutic Index for Nutraceuticals in Inflammation-Related Diseases: Efficacy, Bioavailability, Metabolism and Interactions With Drugs
por: Peluso, Ilaria, et al.
Publicado: (2020)

Editorial: Natural Product Based Drugs that Control Obesity and Other Disorders that Trigger and Provoke Inflammation
por: Youssef, Fadia S., et al.
Publicado: (2022)

Editorial: Chronic Inflammation and Neurodegeneration in Retinal Disease
por: Petrillo, Francesco, et al.
Publicado: (2021)

Editorial: Novel Anti-Inflammatory Approaches for Cystic Fibrosis Lung Disease: Identification of Molecular Targets and Design of Innovative Therapies
por: Ribeiro, Carla Maria Pedrosa, et al.
Publicado: (2021)

Editorial: Novel Drugs Targeting the Microenvironment and the Epigenetic Changes in Hematopoietic Malignancies
por: Gulei, Diana, et al.
Publicado: (2020)

Editorial: Autophagy in Inflammation Related Diseases
por: Shao, Bo-Zong, et al.
Publicado: (2022)

Editorial: Eicosanoids and cytokines: Resolution of inflammation
por: Liu, Jun-Yan
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nunt3mb801e4d4elbccfttg9sd